Treatment of acute exacerbations of asthma in children with a doubling of the usual inhaled corticosteroid (ICS) dose.

Completed

• Conditions: Asthma; Respiratory - Asthma

• Registration Number: ACTRN12605000631606
• Lead Sponsor: Asthma Foundation Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Currently using 125mcg or greater of inhaled Cortico-steroid dailyExacerbation of asthma in past 12/12 requiring Oral Steroid

Exclusion Criteria

Children with other respiratory diseases such as cystic fibrosis. Children with other significant medical conditions that may affect growth.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine whether doubling inhaled corticosteroids at the first sign of a cold or of asthma deterioration in children on preventive treatment with inhaled corticosteroids leads to a reduced need for oral steroid rescue or reduced risk of admission to hospital.[At the time of admission]

Secondary Outcome Measures

Name	Time	Method
Time for peak flow values and spirometry to return to baseline in children old enough to perform lung function[at the first sign of a cold or of asthma deterioration ];School days missed in school aged children.[at the first sign of a cold or of asthma deterioration ]